<table id="table8" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8 Drug Interactions:  Changes in Pharmacokinetic Parameters for Coadministered Drug in the Presence of Tenofovir</caption>
<col align="left" valign="middle" width="21%"></col>
<col align="center" valign="middle" width="21%"></col>
<col align="center" valign="middle" width="10%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<col align="center" valign="middle" width="16%"></col>
<thead>
<tr>
<th rowspan="2" stylecode="Lrule Rrule">Coadministered Drug</th>
<th rowspan="2" stylecode="Rrule">Dose of Coadministered Drug (mg)</th>
<th rowspan="2" stylecode="Rrule">N</th>
<th colspan="3" stylecode="Rrule Botrule">% Change of Coadministered Drug Pharmacokinetic Parameters<footnote>
<paragraph>Increase = ↑; Decrease = ↓; No Effect = <rendermultimedia referencedobject="MM3"></rendermultimedia>; NA = Not Applicable</paragraph>
</footnote>
<br/> (90% CI)</th>
</tr>
<tr stylecode="Botrule">
<th align="center" stylecode="Rrule">C<sub>max</sub>
</th>
<th stylecode="Rrule">AUC</th>
<th stylecode="Rrule">C<sub>min</sub>
</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Abacavir</td>
<td stylecode="Rrule">300 once</td>
<td stylecode="Rrule">8</td>
<td stylecode="Rrule">↑ 12<br/> (↓ 1 to ↑ 26)</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">NA</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir<footnote id="t8ftb">Reyataz Prescribing Information</footnote>
</td>
<td stylecode="Rrule">400 once daily × 14 days</td>
<td stylecode="Rrule">34</td>
<td stylecode="Rrule">↓ 21<br/> (↓ 27 to ↓ 14)</td>
<td stylecode="Rrule">↓ 25<br/> (↓ 30 to ↓ 19)</td>
<td stylecode="Rrule">↓ 40<br/> (↓ 48 to ↓ 32)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir<footnoteref idref="t8ftb"></footnoteref>
</td>
<td stylecode="Rrule">Atazanavir/Ritonavir 300/100 once daily × 42 days</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">↓ 28<br/> (↓ 50 to ↑ 5)</td>
<td stylecode="Rrule">↓ 25<footnote id="t8ftc">In HIV-infected subjects, addition of tenofovir DF to atazanavir 300 mg plus ritonavir 100 mg, resulted in AUC and C<sub>min</sub> values of atazanavir that were 2.3 and 4-fold higher than the respective values observed for atazanavir 400 mg when given alone.</footnote>
<br/> (↓ 42 to ↓ 3)</td>
<td stylecode="Rrule">↓ 23<footnoteref idref="t8ftc"></footnoteref>
<br/> (↓ 46 to ↑ 10)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz </td>
<td stylecode="Rrule">600 once daily × 14 days</td>
<td stylecode="Rrule">30</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Emtricitabine</td>
<td stylecode="Rrule">200 once daily × 7 days</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">↑ 20<br/> (↑ 12 to ↑ 29)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Indinavir</td>
<td stylecode="Rrule">800 three times daily × 7 days</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↓ 11<br/> (↓ 30 to ↑ 12)</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Entecavir</td>
<td stylecode="Rrule">1 mg once daily × 10 days</td>
<td stylecode="Rrule">28</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">↑ 13<br/>(↑ 11 to ↑ 15)</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lamivudine</td>
<td stylecode="Rrule">150 twice daily × 7 days</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↓ 24<br/> (↓ 34 to ↓ 12)</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Lopinavir</td>
<td rowspan="2" stylecode="Rrule Botrule">Lopinavir/Ritonavir 400/100 twice daily × 14 days</td>
<td rowspan="2" stylecode="Rrule Botrule">24</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ritonavir</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Methadone<footnote>R-(active), S- and total methadone exposures were equivalent when dosed alone or with VIREAD.</footnote>
</td>
<td stylecode="Rrule">40–110 once daily × 14 days<footnote>Individual subjects were maintained on their stable methadone dose. No pharmacodynamic alterations (opiate toxicity or withdrawal signs or symptoms) were reported.</footnote>
</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Nelfinavir</td>
<td rowspan="2" stylecode="Rrule Botrule">1250 twice daily × 14 days</td>
<td rowspan="2" stylecode="Rrule Botrule">29</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">M8 metabolite</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Oral Contraceptives<footnote>Ethinyl estradiol and 17-deacetyl norgestimate (pharmacologically active metabolite) exposures were equivalent when dosed alone or with VIREAD.</footnote>
</td>
<td stylecode="Rrule">Ethinyl Estradiol/ Norgestimate (Ortho-Tricyclen) Once daily × 7 days</td>
<td stylecode="Rrule">20</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ribavirin</td>
<td stylecode="Rrule">600 once</td>
<td stylecode="Rrule">22</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">NA</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Saquinavir</td>
<td rowspan="2" stylecode="Rrule Botrule">Saquinavir/Ritonavir 1000/100 twice daily × 14 days</td>
<td rowspan="2" stylecode="Rrule Botrule">32</td>
<td stylecode="Rrule">↑ 22<br/> (↑ 6 to ↑41)</td>
<td stylecode="Rrule">↑ 29<footnote id="t8ftg">Increases in AUC and C<sub>min</sub> are not expected to be clinically relevant; hence no dose adjustments are required when tenofovir DF and ritonavir-boosted saquinavir are coadministered.</footnote>
<br/> (↑ 12 to ↑ 48)</td>
<td stylecode="Rrule">↑ 47<footnoteref idref="t8ftg"></footnoteref>
<br/> (↑ 23 to ↑ 76)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ritonavir</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">↑ 23<br/> (↑ 3 to ↑ 46)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Tacrolimus</td>
<td stylecode="Rrule">0.05 mg/kg twice daily × 7 days</td>
<td stylecode="Rrule">21</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
<td stylecode="Rrule">
<rendermultimedia referencedobject="MM3"></rendermultimedia>
</td>
</tr>
</tbody>
</table>